All Posts

By Sasha Stafford | Principal Scientist and Founder | Elixis Biosciences Published: September 2026 The Silent Breakdown of Modern Pharmacotherapy We often evaluate clinical therapeutics through the lens of molecular efficacy: how tightly an antibody binds its target, how potently a small molecule inhibits an enzyme, or how low an antibiotic’s Minimum Inhibitory Concentration (MIC) is. Yet, in real-world clinical practice, therapeutic success hinges on a far more fragile varia

# The Deliverome Project: Revolutionizing Drug Delivery in Precision Medicine By Sasha Stafford Principal Scientist & Founder, Elixis Biosciences LLC In the modern era of precision medicine, an unprecedented toolkit of therapeutic payloads is available. Today’s scientists can engineer CAR-T cells to eradicate blood cancers, design antisense oligonucleotides to silence harmful genes, and construct highly specific antibody-drug conjugates (ADCs). However, the promise of these r

The evolution of drug delivery systems has been pivotal in enhancing therapeutic efficacy and patient compliance. The development of advanced drug delivery systems (ADDS) represents a significant leap forward in pharmaceutical technology, enabling precise control over drug release profiles, targeted delivery, and improved bioavailability. These innovations address the limitations of conventional dosage forms, such as poor solubility, rapid metabolism, and systemic side effect